PT - JOURNAL ARTICLE AU - Ruff, Ryan Richard AU - Paul, Bidisha AU - Sierra, Maria A AU - Xu, Fangxi AU - Crystal, Yasmi AU - Li, Xin AU - Saxena, Deepak TI - Treatment nonresponse in children receiving silver diamine fluoride for caries: A pilot study AID - 10.1101/2020.10.02.20204743 DP - 2020 Jan 01 TA - medRxiv PG - 2020.10.02.20204743 4099 - http://medrxiv.org/content/early/2020/10/05/2020.10.02.20204743.short 4100 - http://medrxiv.org/content/early/2020/10/05/2020.10.02.20204743.full AB - Objectives: Silver diamine fluoride (SDF) is a nonsurgical therapy for the arrest and prevention of dental caries with demonstrated clinical efficacy. Approximately 20% of children receiving SDF fail to respond to treatment. The objective of this study was to develop a predictive model of treatment nonresponse using machine learning. Methods: An observational pilot study (N=20) consisting of children with and without active decay and who did and did not respond to silver diamine fluoride provided salivary samples and plaque from infected and contralateral sites. 16S rRNA genes from samples were amplified and sequenced on an Illumina Miseq and analyzed using QIIME. The association between operational taxonomic units and treatment nonresponse was assessed using lasso regression and artificial neural networks. Results: Bivariate group comparisons of bacterial abundance indicate a number of genera were significantly different between nonresponders and those who responded to SDF therapy. No differences were found between nonresponders and caries-active subjects. Prevotella pallens and Veillonella denticariosi were retained in full lasso models and combined with clinical variables in a six-input multilayer perceptron. Discussion: The acidogenic and acid-tolerant nature of retained bacterial species may overcome the antimicrobial effects of SDF. Further research to validate the model in larger external samples is needed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded in part by awards from the New York University Grant Support Initiative (#RA633, Ruff PI) and the National Institute of Dental and Craniofacial Research (#R56DE028933, Ruff PI). The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Institutes of Health, New York University, the New York University College of Dentistry, or the New York University School of Medicine. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study received approval from the New York University School of Medicine Institutional Re- view Board (#s19-00692, The role of the oral microbiome in predicting disparities in caries and responsiveness to caries prevention: An observational pilot study, 23 June 2019)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCode and models are available at a GitHub repository (www.github.com/ryanruff/nonresponse). Data available upon request and review. http://www.github.com/ryanruff/nonresponse